Immunome, Inc.
IMNM
$19.37
$2.2813.34%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -21.99% | -20.14% | 67.84% | 13.37% | -984.00% |
| Total Depreciation and Amortization | 28.37% | 6.98% | 176.05% | 131.52% | 243.98% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -41.92% | -45.22% | -95.70% | -61.00% | 615.55% |
| Change in Net Operating Assets | 361.91% | -510.37% | -479.71% | 166.74% | 138.24% |
| Cash from Operations | -18.56% | -111.14% | -374.98% | -140.91% | -296.64% |
| Capital Expenditure | 27.49% | 61.39% | -69.36% | -222.64% | -4,175.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 387.58% | 20.26% | 124.96% | 127.96% | -- |
| Cash from Investing | 414.08% | 21.44% | 113.67% | 132.52% | 67,038.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 8,997.84% | -81.51% | -26.06% | 5,421.56% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -350.49% | 42.43% | 25.93% | -100.73% | -100.34% |
| Cash from Financing | 14,781.64% | -107.93% | -26.07% | -63.81% | -99.50% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,418.75% | -8.85% | -33.20% | -251.99% | -118.70% |